argenx SE (ARGX)

875.33 +1.62 (+0.19%) USD  |  NASDAQ  |  Oct 26, 13:57
More

argenx Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for ARGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Autolus Therapeutics Plc Upgrade
Cellectis SA Upgrade
Akari Therapeutics Plc --
Forte Biosciences, Inc. --
DBV Technologies SA --